Pleiotropic Effects of Statins on the Cardiovascular System

Cited by (1,000)

Items 301–400 of 1,000

1. Regulatory Effects of Statins on SIRT1 and Other Sirtuins in Cardiovascular Diseases
   Danial Khayatan, Seyed Mehrad Razavi, Zahra Najafi Arab, Maryam Khanahmadi, Saeideh Momtaz, Alexandra E. Butler, Fabrizio Montecucco, Yuliya V. Markina, Amir Hossein Abdolghaffari, Amirhossein Sahebkar · 2022 · Life
2. Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events
   Masashi Sakuma, Satoshi Iimuro, Tomohiro Shinozaki, Takeshi Kimura, Yoshihisa Nakagawa, Yukio Ozaki, Hiroshi Iwata, Katsumi Miyauchi, Hiroyuki Daida, Satoru Suwa et al. · 2022 · BMC Medicine
3. Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases
   Quentin Delbaere, Nicolas Chapet, Fabien Huet, Clément Delmas, Nathan Mewton, Fabrice Prunier, Denis Angoulvant, François Roubille · 2023 · Pharmaceuticals
4. Rosuvastatin suppresses TNF-α-induced matrix catabolism, pyroptosis and senescence via the HMGB1/NF-κB signaling pathway in nucleus pulposus cells
   Weijian Chen, Zhihuai Deng, Jianxiong Zhu, Liang Yuan, Shuangxing Li, Yangyang Zhang, Jiajun Wu, Zhengqi Huang, Tianyu Qin, Wei Ye · 2023 · Acta Biochimica et Biophysica Sinica
5. Treatment with PCSK9 Inhibitor Evolocumab Improves Vascular Oxidative Stress and Arterial Stiffness in Hypercholesterolemic Patients with High Cardiovascular Risk
   Silla, Alessia, Fogacci, Federica, Punzo, Angela, Hrelia, Silvana, Simoni, Patrizia, Caliceti, Cristiana, Cicero, Arrigo F. G. · 2023 · Antioxidants
6. Medical Management of Dyslipidemia for Secondary Stroke Prevention: Narrative Review
   Yoonkyung Chang, Soojeong Eom, Min-Jeong Kim, Tae‐Jin Song · 2023 · Medicina
7. Old wines in new bottles: Repurposing opportunities for Parkinson's disease
   Ashish Kumar Kakkar, Harmanjit Singh, Bikash Medhi · 2018 · European Journal of Pharmacology
8. The Crosstalk Between Immune Activation and Metabolism in Heart Failure. A Scientific Statement of the Heart Failure Association of the ESC
   Gabriele Fragasso, Davide Stolfo, Markus S. Anker, Antoni Bayés‐Genís, Ovidiu Chioncel, Stephane R B Heymans, Pardeep S. Jhund, Basil S. Lewis, Gary D. Lopaschuk, Lars H Lund et al. · 2025 · European Journal of Heart Failure
9. Platelet Redox Imbalance in Hypercholesterolemia: A Big Problem for a Small Cell
   Alessandro Morotti, Cristina Barale, Elena Melchionda, Isabella Russo · 2022 · International Journal of Molecular Sciences
10. Lactate dehydrogenase is associated with flow-mediated dilation in hypertensive patients
    Xiaoqi Cai, Tingjun Wang, Liangdi Xie · 2023 · Scientific Reports
11. Clinical effects of antiplatelet drugs and statins on D‐dimer levels
    Suzanne Schol‐Gelok, Tom van der Hulle, Joseph S. Biedermann, Teun van Gelder, Frederikus Albertus Klok, Liselotte M. van der Pol, Jorie Versmissen, Menno Volkert Huisman, Marieke J.H.A. Kruip · 2018 · European Journal of Clinical Investigation
12. Strategies to Prevent Cardiotoxicity
    Jason P. Graffagnino, Lavanya Kondapalli, Garima Arora, Riem Hawi, Carrie Geisberg Lenneman · 2020 · Current Treatment Options in Oncology
13. Implications of endoplasmic reticulum stress and autophagy in aging and cardiovascular diseases
    Chenguang Ma, Yang Liu, Zhiling Fu · 2024 · Frontiers in Pharmacology
14. Best Treatment Strategies With Statins to Maximize the Cardiometabolic Benefits
    Kyoung Im Cho, Ichiro Sakuma, Il Suk Sohn, Toshio Hayashi, Kazunori Shimada, Kwang Kon Koh · 2018 · Circulation Journal
15. Statins and Bempedoic Acid: Different Actions of Cholesterol Inhibitors on Macrophage Activation
    Rebecca Linnenberger, Jessica Hoppstädter, Selina Wrublewsky, Emmanuel Ampofo, Alexandra K. Kiemer · 2021 · International Journal of Molecular Sciences
16. Cardioprotective Strategies for Doxorubicin-induced Cardiotoxicity: Present and Future
    Aleksey Michailovich Chaulin, Dmitry Viktorovich Duplyakov · 2022 · Rational Pharmacotherapy in Cardiology
17. Atorvastatin Ameliorates Lipid Overload-Induced Mitochondrial Dysfunction and Myocardial Hypertrophy by Decreasing Fatty Acid Oxidation Through Inactivation of the p-STAT3/CPT1 Pathway
    Peng Zheng, Hengfang Wu, Yilu Gu, Li Luo, Ran Hu, Wenjing Ma, Zhiping Bian, Nannan Liu, Di Yang, Xiangjian Chen · 2022 · Biomedicine & Pharmacotherapy
18. Use of Statins in Heart Failure with Preserved Ejection Fraction: Current Evidence and Perspectives
    Artem G. Ovchinnikov, Alexandra V. Potekhina, Tatiana I. Arefieva, A. Yu. Filatova, Fail T. Ageev, Evgeny Belyavskiy · 2024 · International Journal of Molecular Sciences
19. Atorvastatin Reduces Plasma Inflammatory and Oxidant Biomarkers in Patients With Risk of Atherosclerotic Cardiovascular Disease
    Fadia Mayyas, Duha Baydoun, Rasheed Ibdah, Khalid S Ibrahim · 2018 · Journal of Cardiovascular Pharmacology and Therapeutics
20. Influenza, evolution, and the next pandemic
    David S. Fedson · 2018 · Evolution Medicine and Public Health
21. Association of Statin Use and Mortality After Transcatheter Aortic Valve Replacement
    Poghni Peri-Okonny, Yangbo Liu, S. Chris Malaisrie, Chetan Prakash Huded, Samir Ramesh Kapadia, Vinod H. Thourani, Susheel Kodali, John G. Webb, Thomas McAndrew, Martin B. Leon et al. · 2019 · Journal of the American Heart Association
22. Management of dyslipidaemia in patients with chronic kidney disease: a position paper endorsed by the Italian Society of Nephrology
    Roberto Pontremoli, Vincenzo Bellizzi, Stefano Bianchi, Roberto Bigazzi, Valeria Cernaro, Lucia Del Vecchio, Luca De Nicola, Giovanna Leoncini, Francesca Mallamaci, Carmine Zoccali et al. · 2020 · Journal of Nephrology
23. Lipid‐based gene delivery to macrophage mitochondria for atherosclerosis therapy
    Felix Zakirov, Dongwei Zhang, Andrey V. Grechko, Wei‐Kai Wu, Anastasia Vladimirovna Poznyak, Alexander Nikolaevich Orekhov · 2020 · Pharmacology Research & Perspectives
24. Does Lowering Low‐Density Lipoprotein Cholesterol With Statin Restore Low Risk in Middle‐Aged Adults? Analysis of the Observational MESA Study
    Kiang Liu, John T. Wilkins, Laura Anne Colangelo, Donald M. Lloyd‐Jones · 2021 · Journal of the American Heart Association
25. Brief Report: Statin Effects on Myocardial Fibrosis Markers in People Living With HIV
    Christopher R. deFilippi, Robert H. Christenson, Jessica M. Joyce, Jakob Park, Ashley Y. Wu, Kathleen V. Fitch, Sara E. Dolan Looby, Michael T. Lu, Udo Hoffmann, Steven Kyle Grinspoon et al. · 2018 · JAIDS Journal of Acquired Immune Deficiency Syndromes
26. The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies
    Dimitris C. Kounatidis, Nikolaοs Tentolouris, Natalia G. Vallianou, Iordanis S. Mourouzis, Ιrene Karampela, Theodora Stratigou, Eleni Rebelos, Marina Kouveletsou, Vasileios Stamatopoulos, Eleni Tsaroucha et al. · 2024 · Metabolites
27. Treatment of endothelial cell dysfunction in atherosclerosis: a new perspective integrating traditional and modern approaches
    Luqun Yang, Xinjian Li, Lin Ni, Yuanyuan Lin · 2025 · Frontiers in Physiology
28. Three Musketeers for Lowering Cholesterol: Statins, Ezetimibe and Evolocumab
    Qian Xu, Yiming Deng, Jun Hai Xiao, Xiangrui Liu, Min Zhou, Zhong Ren, Juan Peng, Yaling Tang, Zhi‐Sheng Jiang, Zhi‐Han Tang et al. · 2020 · Current Medicinal Chemistry
29. Protective Effects of Statin and Angiotensin Receptor Blocker in a Rat Model of Doxorubicin- and Trastuzumab-Induced Cardiomyopathy
    Dong‐Hyuk Cho, I-Rang Lim, Jong-Ho Kim, Mi‐Na Kim, Yong‐Hyun Kim, Kyong Hwa Park, Seong‐Mi Park, Wan Joo Shim · 2020 · Journal of the American Society of Echocardiography
30. Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility
    Tarek Kashour, Rabih Halwani, Yaseen M. Arabi, Muhammad Rizwan Sohail, John Charles O’Horo, Andrew D. Badley, Imad M. Tleyjeh · 2021 · Immunopharmacology and Immunotoxicology
31. Antiangiogenic and Proapoptotic Activities of Atorvastatin and Ganoderma lucidum in Tumor Mouse Model via VEGF and Caspase-3 Pathways
    Iman Hesham EL-Khashab · 2021 · Asian Pacific Journal of Cancer Prevention
32. The Risk Factors of Blood Cadmium Elevation in Chronic Kidney Disease
    Kai‐Fan Tsai, Pai-Chin Hsu, Chia‐Te Kung, Chien‐Te Lee, Huey‐Ling You, Wan‐Ting Huang, Shau-Hsuan Li, Fu‐Jen Cheng, Chin‐Chou Wang, Wen‐Chin Lee · 2021 · International Journal of Environmental Research and Public Health
33. Effectiveness of a Novel Nutraceutical Compound Containing Red Yeast Rice, Polymethoxyflavones and Antioxidants in the Modulation of Cholesterol Levels in Subjects With Hypercholesterolemia and Low-Moderate Cardiovascular Risk: The NIRVANA Study
    Paolo Cimaglia, Francesco Vieceli Dalla Sega, Francesco Vitali, Veronica Lodolini, Davide Bernucci, Giulia Passarini, Francesca Fortini, Luisa Marracino, Giorgio Aquila, Paola Rizzo et al. · 2019 · Frontiers in Physiology
34. Clinically relevant endothelial nitric oxide synthase polymorphisms and their impact on drug response
    Cezar Kayzuka Cotta Filho, Gustavo Henrique Oliveira‐Paula, Vitória Carolina Rondon Pereira, Riccardo Lacchini · 2020 · Expert Opinion on Drug Metabolism & Toxicology
35. IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis
    Vanessa A Marchant, Antonio Tejera‐Muñoz, Laura Márquez‐Expósito, Sandra Rayego‐Mateos, Raúl R. Rodrigues-Díez, Lucía Tejedor-Santamaria, Laura Santos‐Sanchez, Jesús Egido, Alberto Ortíz, José Manuel Valdivielso et al. · 2020 · Biomolecules
36. Rho GTPase regulation of reactive oxygen species generation and signalling in platelet function and disease
    Anh T. P. Ngo, Iván Parra‐Izquierdo, Joseph E. Aslan, Owen J. T. McCarty · 2021 · Small GTPases
37. Key Enzymes for the Mevalonate Pathway in the Cardiovascular System
    Zhang, Chi, Jin, Dan-Dan, Wang, Xi-Ying, Lou, Lian, Yang, Jian · 2021 · Journal of Cardiovascular Pharmacology
38. Effect of combined acetylsalicylic acid and statins treatment on intracranial aneurysm rupture
    Mikel Terceño, Sebastián Remollo, Yolanda Silva, Saima Bashir, Mariano Werner, Víctor A Vera-Monge, Joaquin L Serena, Carlos Castaño · 2021 · PLoS ONE
39. Novel function of fluvastatin in attenuating oxidized low‑density lipoprotein‑induced endothelial cell ferroptosis in a glutathione peroxidase4‑ and cystine‑glutamate antiporter‑dependent manner
    Qing Li, Chang Liu, Liang Deng, Enrui Xie, Nishant Yadav, Yuanyuan Tie, Cheng Zheng, Jie Deng · 2021 · Experimental and Therapeutic Medicine
40. Endothelial Yin Yang 1 Phosphorylation at S118 Induces Atherosclerosis Under Flow
    Shu-Yi Wei, Yu-Tsung Shih, Hsin-Yi Wu, Wei-Li Wang, Pei-Ling Lee, Chih-I Lee, Chia-Yu Lin, Yu-Ju Chen, Shu Chien, Jeng-Jiann Chiu · 2021 · Circulation Research
41. Synergistic actions between angiotensin-converting enzyme inhibitors and statins in atherosclerosis
    Claudio Borghi, Bernard I Levy · 2021 · Nutrition Metabolism and Cardiovascular Diseases
42. Statin Use in Patients With Chronic Liver Disease and Cirrhosis: Current Evidence and Future Directions
    Malek Kreidieh, Rachelle Hamadi, Mira Alsheikh, Hassan Al Moussawi, Liliane S. Deeb · 2022 · Gastroenterology Research
43. Statins and angiogenesis in non-cardiovascular diseases
    Fatemeh Zahedipour, Alexandra E. Butler, Manfredi Rizzo, Amirhossein Sahebkar · 2022 · Drug Discovery Today
44. The Pillars for Renal Disease Treatment in Patients with Type 2 Diabetes
    Jessica Kearney, Luigi Gnudi · 2023 · Pharmaceutics
45. Roles of Oxidative Injury and Nitric Oxide System Derangements in Kawasaki Disease Pathogenesis: A Systematic Review
    Mitsuru Tsuge, Kazuhiro Uda, Takahiro Eitoku, Naomi Matsumoto, Takashi Yorifuji, Hirokazu Tsukahara · 2023 · International Journal of Molecular Sciences
46. The Essential Strategies to Mitigate Cardiotoxicity Caused by Doxorubicin
    Aleksey Michailovich Chaulin · 2023 · Life
47. Myocardial Infarction with Nonobstructive Coronary Arteries: The Importance of Achieving Secondary Prevention Targets
    Kai M. Eggers, Nermin Hadziosmanovic, Tomasz Baron, Kristina Hambræus, Tomas Jernberg, Anna M. Nordenskjöld, Per Tornvall, Bertil Lindahl · 2017 · The American Journal of Medicine
48. A strategy for screening bioactive components from natural products based on two-dimensional cell membrane chromatography and component-knockout approach
    Run‐Zhou Liu, Rui Wang, Hai-Ming An, Xinguang Liu, Chao-Ran Li, Ping Li, Hua Qiang Yang · 2019 · Journal of Chromatography A
49. Statins attenuate antiviral IFN‐β and ISG expression via inhibition of IRF3 and JAK/STAT signaling in poly(I:C)‐treated hyperlipidemic mice and macrophages
    Atsushi Koike, Kaito Tsujinaka, Ko Fujimori · 2021 · FEBS Journal
50. Cost-Effectiveness of Icosapent Ethyl, Evolocumab, Alirocumab, Ezetimibe, or Fenofibrate in Combination with Statins Compared to Statin Monotherapy
    Michaeli, Daniel Tobias, Michaeli, Julia Caroline, Boch, Tobias, Michaeli, Thomas · 2022 · Clinical Drug Investigation
51. Current Approaches and Innovations in Managing Preeclampsia: Highlighting Maternal Health Disparities
    Alexis G. Dickerson, Christiana A. Joseph, Khosrow Kashfi · 2025 · Journal of Clinical Medicine
52. Inhibition of the mevalonate pathway improves myocardial fibrosis
    Huifeng Xu, Yi Xin Shen, Chenyu Liang, Haifeng Wang, Junling Huang, Pengcheng Xue, Ming Luo · 2021 · Experimental and Therapeutic Medicine
53. Epicardial Adipose Tissue as an Independent Cardiometabolic Risk Factor for Coronary Artery Disease
    Nikoleta Karampetsou, Leonidas G. Alexopoulos, Aggeliki Minia, Vaia Pliaka, Nikos Tsolakos, Konstantinos Kontzoglou, Despoina N Perrea, Paulos Patapis · 2022 · Cureus
54. Role of statins in the management of dyslipidaemia
    Saumitra Ray · 2024 · Indian Heart Journal
55. Lipids, lipoproteins, and apolipoproteins: Associations with cognition and dementia
    Ida Juul Rasmussen, Jiao Min Luo, Ruth Frikke‐Schmidt · 2024 · Atherosclerosis
56. Different Effects of Pravastatin on Preeclampsia-like Symptoms in Different Mouse Models
    Jing Huai, Zi Yang, Yanhong Yi, Guang-Jiao Wang · 2018 · Chinese Medical Journal
57. Effect of 12-month intervention with low-dose atorvastatin on pulse wave velocity in subjects with type 2 diabetes and dyslipidaemia
    Pinelopi Grigoropoulou, Anastasios Tentolouris, Ioanna Eleftheriadou, Dimitrios Tsilingiris, Charalambos V. Vlachopoulos, Maria Sykara, Nikolaοs Tentolouris · 2018 · Diabetes and Vascular Disease Research
58. Repurposing drugs to target nonalcoholic steatohepatitis
    Silvia Sookoian, Carlos Jose Pirola · 2019 · World Journal of Gastroenterology
59. Current pharmacotherapy for the treatment of dyslipidemia associated with HIV infection
    Anna Gebhardt, Carl J. Fichtenbaum · 2019 · Expert Opinion on Pharmacotherapy
60. miR-532-3p-CSF2RA Axis as a Key Regulator of Vulnerable Atherosclerotic Plaque Formation
    Rongzhong Huang, Yu Qing Cao, Hongrong Li, Zicheng Hu, Hong Zhang, Lujun Zhang, Wenhua Su, Yu Xu, Liwen Liang, Narayan D. Melgiri et al. · 2019 · Canadian Journal of Cardiology
61. Atorvastatin Enhances Foam Cell Lipophagy and Promotes Cholesterol Efflux Through the AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway
    Shuzhan Zheng, Yanfei Du, Qiang Ye, Kelan Zha, Jian Feng · 2020 · Journal of Cardiovascular Pharmacology
62. The Basics of Metabolic Dysfunction–Associated Steatotic Liver Disease for Cardiologists
    Muhammad Shahzeb Khan, Syed Sarmad Javaid, Amreen M. Dinani, Kara Wegermann, Ambarish Pandey, Ankeet S. Bhatt, Mark Dhinesh Muthiah, Harriette G.C. Van Spall, Faiez M. Zannad, Javed Butler et al. · 2025 · Journal of the American College of Cardiology
63. La activación plaquetaria como factor desencadenante de la inflamación y la ateroesclerosis
    Elba Reyes‐Maldonado, Ruth Angélica Lezama, Santiago J. Custodio-Chablé · 2020 · Cirugía y Cirujanos
64. Cardiac fibrosis: emerging agents in preclinical and clinical development
    Roberto Spoladore, Giulio Falasconi, Giorgio Fiore, Silvana Di Maio, Alberto Preda, Massimo Slavich, Alberto Margonato, Gabriele Fragasso · 2020 · Expert Opinion on Investigational Drugs
65. Untargeted fecal metabolomics revealed biochemical mechanisms of the blood lipid-lowering effect of koumiss treatment in patients with hyperlipidemia
    Bohai Li, Fan Hui, Yuan Zhang, Qingxiang Shang, Shuai Guo, Yingshu Bao, Yongfu Chen · 2021 · Journal of Functional Foods
66. Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19
    Gonzalo Cabezón Villalba, Ignacio Jesus Amat-Santos, Carlos Dueñas, Diego López‐Otero, Pablo Catalá, Álvaro Aparisi, Javier López‐País, Carla Eugenia Cacho Antonio, Jordi Candela, Pablo José Antúnez Muiños et al. · 2021 · Cardiology Journal
67. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells
    Álvaro Cerda, Raul Hernandes Bortolin, Victor Manríquez, Luis Antonio Salazar, Tomás Zambrano, Cristina Moreno Fajardo, Mário Hiroyuki Hirata, Rosário Dominguez Crespo Hirata · 2021 · Pharmacological Reports
68. Association between statin use and the risks of glaucoma in Australia: a 10-year cohort study
    Yixiong Yuan, Wei Wang, Xianwen Shang, Ruilin Xiong, Jason James Ha, Lei Zhang, Zhuoting Zhu, Mingguang He · 2021 · British Journal of Ophthalmology
69. Statin therapy and its association with long-term survival after colon cancer surgery
    Arvid Pourlotfi, Rebecka Ahl, Maximilian Peter Forssten, Gabriel Sjölin, Gary Alan Bass, Yang Cao, Peter Matthiessen, Shahin Mohseni · 2021 · Surgery
70. Comparison of the Effects of High-intensity Statin Therapy with Moderate-Intensity Statin and Ezetimibe Combination Therapy on Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction: a Nationwide Cohort Study
    Kihyun Kim, Woo-Dae Bang, Kyungdo Han, Bongseong Kim, Jung‐Myung Lee, Hyemoon Chung · 2021 · Journal of Lipid and Atherosclerosis
71. The effect of various types and doses of statins on C-reactive protein levels in patients with dyslipidemia or coronary heart disease: A systematic review and network meta-analysis
    Jie Zhang, Xinyi Wang, Wende Tian, Tongxin Wang, Jundi Jia, Runmin Lai, Tong Wang, Zihao Zhang, Luxia Song, Jianqing Ju et al. · 2022 · Frontiers in Cardiovascular Medicine
72. Central and Brachial Blood Pressures, Statins, and Low-Density Lipoprotein Cholesterol
    Florence Lamarche, Mohsen Agharazii, Annie‐Claire Nadeau‐Fredette, François Madore, Rémi Goupil · 2018 · Hypertension
73. Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis
    Chuannan Zhai, Kai Hou, Rui Li, Yuecheng Hu, Jingxia Zhang, Zhang Yingyi, Le Wang, Rui Zhang, Hongliang Cong · 2020 · Journal of International Medical Research
74. Effects of High-Dose Rosuvastatin on Ventricular Remodelling and Cardiac Function in ST-Segment Elevation Myocardial Infarction
    Rong Luo, Xiaochen Sun, Feiyan Shen, Bin Hong, Zilong Wang · 2020 · Drug Design Development and Therapy
75. Statin Effects in Atrial Fibrillation-Related Stroke: A Systematic Review and Meta-Analysis
    Mi‐Yeon Eun, Jin‐Man Jung, Kang‐Ho Choi, Woo‐Keun Seo · 2020 · Frontiers in Neurology
76. Association between statin use and the risk, prognosis of gynecologic cancer: A meta-analysis
    Yali Chen, Ling Han, Ai Zheng · 2021 · European Journal of Obstetrics & Gynecology and Reproductive Biology
77. An overview on nanoplatforms for statins delivery: Perspectives for safe and effective therapy
    Etemad, Leila, Salmasi, Zahra, Moosavian Kalat, Seyedeh Alia, Moshiri, Mohammad, Zamanian, Javad, Kesharwani, Prashant, Sahebkar, Amirhossein · 2023 · Environmental Research
78. Triglycerides, Triglyceride-Rich Lipoproteins, and Remnant Cholesterol in Atherosclerotic Cardiovascular Disease
    Sang‐Ho Jo · 2025 · Journal of Lipid and Atherosclerosis
79. Effect of statin treatment on circulating malondialdehyde concentrations: a systematic review and meta-analysis
    Angelo Zinellu, Panagiotis Paliogiannis, Maria Franca Usai, Ciriaco Carru, Arduino Aleksander Mangoni · 2019 · Therapeutic Advances in Chronic Disease
80. Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
    Geert Byttebier, Luc Belmans, Myriam Alexander, Bo E. H. Saxberg, Bart M. J. De Spiegeleer, Anton De Spiegeleer, Nick Devreker, Jens Tomas Van Praet, Karolien Vanhove, Reinhilde Reybrouck et al. · 2021 · Human Vaccines & Immunotherapeutics
81. Atorvastatin Pretreatment Ameliorates Mesenchymal Stem Cell Migration through miR-146a/CXCR4 Signaling
    Na Li, Xueyuan Guo, Jian Zhou, Xianliang Yan, Fangfang Yu · 2021 · Tissue Engineering and Regenerative Medicine
82. Oleic acid triggers metabolic rewiring of T cells poising them for T helper 9 differentiation
    Nathalie A. Reilly, Friederike Sonnet, Koen F. Dekkers, Joanneke C. Kwekkeboom, Lucy Sinke, Stan T. Hilt, Hayat M. Suleiman, Marten A. Hoeksema, Hailiang Mei, Erik W. van Zwet et al. · 2024 · iScience
83. Gender differences in LDL- and HDL-cholesterol subfractions in patients after the acute ischemic stroke and their association with oxidative stress markers
    Ingrid Žitňanová, Pavel Šiarnik, Matej Fülöp, Stanislav Oravec, Adela Penesová, Zdeňka Ďuračková, Eva Vaská, Peter Turčáni, Branislav Kollár · 2018 · Journal of Clinical Biochemistry and Nutrition
84. Thrombospondin‐5 and fluvastatin promote angiogenesis and are protective against endothelial cell apoptosis
    Furqan Muqri, Alex W. Helkin, Kristopher G. Maier, Vivian Gahtan · 2020 · Journal of Cellular Biochemistry
85. Meta-analysis of randomized clinical trials comparing PCSK9 monoclonal antibody versus ezetimibe/placebo in patients at high cardiovascular risk
    Wenfang Ma, Xiying Guo, Yiming Ma, Zhao Hu · 2021 · Atherosclerosis
86. Evolocumab for prevention of microvascular dysfunction in patients undergoing percutaneous coronary intervention: the randomised, open-label EVOCATION trial
    Masaharu Ishihara, Masanori Asakura, Kiyoshi Hibi, Kozo Okada, Wataru Shimizu, Hitoshi Takano, Satoru Suwa, Kenshi Fujii, Yasuo Okumura, Toshiaki Mano et al. · 2022 · EuroIntervention
87. Inflammatory biomarkers in patients in Simvastatin treatment: No effect of co-enzyme Q10 supplementation
    Maria Hansen, Anja Birk Kuhlman, Ronni Eg Sahl, Bo Kelly, Thomas Hoffmann Morville, Tine Lovsø Dohlmann, Karoline Maise Chrøis, Steen Larsen, Jørn Wulff Helge, Flemming Dela · 2018 · Cytokine
88. Influence of statin therapy on antiphospholipid antibodies and endothelial dysfunction in young patients with coronary artery disease and systemic lupus erythematosus
    Adam Mazurek, Krzysztof Gryga, Kamil Bugała, Teresa Iwaniec, Jacek Musiał, Piotr Stanisław Podolec, Wojciech Płazak · 2019 · Archives of Medical Science
89. Coronaviruses, cholesterol and statins: Involvement and application for Covid-19
    Stéphane Orlowski, Jean‐Jacques Mourad, Antonio Gallo, Éric Bruckert · 2021 · Biochimie
90. Efficacy of Statin Therapy in Patients with Hospital Admission for COVID-19
    Daein Choi, Qinzhong Chen, Sascha N. Goonewardena, Hannah Pacheco, Priscilla Mejia, Robin L. Smith, Robert S. Rosenson · 2021 · Cardiovascular Drugs and Therapy
91. Combined Therapeutics for Atherosclerosis Treatment Using Polymeric Nanovectors
    Baltazar Hiram Leal-Martínez, Brenda Velasco, Adriana Cambón, Alberto Pardo, Javier Fernández‐Vega, Lilia Arellano, Abeer Al‐Modlej, Vı́ctor Mosquera, Alberto Bouzas‐Mosquera, Gerardo Prieto et al. · 2022 · Pharmaceutics
92. Association of Perceived Stress With Incident Heart Failure
    Lauren Balkan, Joanna Bryan Ringel, Emily B. Levitan, Yulia A. Khodneva, Laura C. Pinheiro, Madeline R. Sterling, Samuel M. Kim, Ian Matthew Kronish, Elizabeth Anne Jackson, Raegan W. Durant et al. · 2022 · Journal of Cardiac Failure
93. Association between plaque vulnerability and neutrophil extracellular traps (NETs) levels: The Plaque At RISK study
    Judith J. de Vries, Anouchska S. A. Autar, Dianne H.K. van Dam-Nolen, Samantha J. Donkel, Mohamed Kassem, Anja G. van der Kolk, Twan J. van Velzen, M. Eline Kooi, Jeroen Hendrikse, Paul J. Nederkoorn et al. · 2022 · PLoS ONE
94. Associations Between Drug Treatments and the Risk of Aneurysmal Subarachnoid Hemorrhage: a Systematic Review and Meta-analysis
    Kampei Shimizu, Tomohiro Aoki, Nima Etminan, Katharina A. M. Hackenberg, Shoichi Tani, Hirotoshi Imamura, Hiroharu Kataoka, Nobuyuki Sakai · 2022 · Translational Stroke Research
95. Atorvastatin-induced tolerogenic dendritic cells improve cardiac remodeling by suppressing TLR-4/NF-κB activation after myocardial infarction
    Qian Wang, Zhaoyang Chen, Junjie Guo, Xiaoping Peng, Zeqi Zheng, Hang Chen, Haibo Liu, Yuanji Ma, Jianbing Zhu · 2022 · Inflammation Research
96. Meta-Analysis of Cardiovascular Risk Factors in Offspring of Preeclampsia Pregnancies
    Weikai Wang, Ru Lin, Lan Yang, Yanxia Wang, Baohong Mao, Xiaoying Xu, Jing Yu · 2023 · Diagnostics
97. Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy
    Emrush Rexhaj, Sarah Bär, Rodrigo Soria, Yasushi Ueki, Jonas Dominik Häner, Tatsuhiko Otsuka, Raminta Kavaliauskaite, George C.M. Siontis, Stefan Stortecky, Hiroki Shibutani et al. · 2024 · Atherosclerosis
98. Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab
    Yanyan Zhang, Zhaohui Pei, Beijian Chen, Yanling Qu, Xiaolin Dong, Binge Yu, Guoqin Wang, Fang Xu, Dongmei Lu, Zhimei He et al. · 2024 · Pharmacological Research
99. Atorvastatin affects negatively respiratory function of isolated endothelial mitochondria
    Izabela Broniarek, Wiesława Jarmuszkiewicz · 2017 · Archives of Biochemistry and Biophysics
100. Cardioprotection in the Modern Era of Cancer Chemotherapy
     Anuradha Godishala, Shu Yang, Aarti H. Asnani · 2018 · Cardiology in Review